| 000 | 01813nam a2200445 i 4500 | ||
|---|---|---|---|
| 999 |
_c291297 _d291297 |
||
| 001 | on1135982782 | ||
| 003 | OCoLC | ||
| 005 | 20200221190157.0 | ||
| 006 | m o d f | ||
| 007 | cr ||||||||||| | ||
| 008 | 200115s2020 dcua ob f000 0 eng c | ||
| 024 | 8 | _a38-796 | |
| 040 |
_aPUCPR _beng _erda _epn _cGPO _dMvI |
||
| 042 | _apcc | ||
| 043 | _an-us--- | ||
| 074 | _a1038-C (online) | ||
| 086 | 0 | _aY 4.F 49:S.HRG.115-727 | |
| 099 | _aY 4.F 49:S.HRG.115-727 | ||
| 110 | 1 |
_aUnited States. _bCongress. _bSenate. _bCommittee on Finance, |
|
| 245 | 1 | 0 |
_aPrescription drug affordability and innovation : _baddressing challenges in today's market : hearing before the Committee on Finance, United States Senate, One Hundred Fifteenth Congress, second session, June 26, 2018. |
| 264 | 1 |
_aWashington : _bU.S. Government Publishing Office, _c2018. |
|
| 300 |
_a1 online resource (iii, 211 pages) : _billustrations. |
||
| 336 | _btxt | ||
| 337 |
_bc _2rdamedia |
||
| 338 |
_bcr _2rdacarrier |
||
| 490 | 1 |
_aS. hrg. ; _v115-727 |
|
| 500 | _aAccess ID (govinfo): CHRG-115shrg38796. | ||
| 500 | _aGPO Cataloging Record Distribution Program (CRDP). | ||
| 504 | _aIncludes bibliographical references. | ||
| 518 | _aDate of hearing: 2018-06-26. | ||
| 588 | _aDescription based on online resource; title from PDF title page (Govinfo websited, viewed Jan 15, 2020). | ||
| 810 | 1 |
_aUnited States. _bCongress. _bSenate. _tS. hrg. ; _v115-727. |
|
| 856 | 4 | 0 | _uhttps://purl.fdlp.gov/GPO/gpo130776 |
| 050 | 4 |
_aKF26 _b.F5 2018p |
|
| 650 | 0 |
_aDrugs _zUnited States _xCosts. |
|
| 650 | 0 |
_aPharmaceutical industry _xEconomic aspects _zUnited States. |
|
| 650 | 0 |
_aPrescription pricing _zUnited States. |
|
| 655 | 7 |
_aLegislative hearings. _2lcgft |
|
| 942 |
_2sudocs _c8 |
||